Curious about our podcast secrets?

Subscribe to our Newsletter and connect on Facebook!
Click here to get the inside scoop—delivered weekly.

HOPA Now

HOPA Now

HOPA Now

We estimate there's a 100% chance this podcast is looking for guests- reach out and make your move!

Topic Category:

Health and Fitness

Topic Sub-Category:

Medicine

(Log in to see email address)

Language:

English

Podcast Stats:

Number of Episodes: 2
Series Type: episodic
Content Type: AUDIO

Podcast Description

Welcome to HOPA Now, a podcast from the Hematology/Oncology Pharmacy Association. Join hosts Benjamin Andrick, PharmD, BCOP and Matt Mueller as they interview guests in the Hem/Onc pharmacy world to provide insight into the topics that Hematology/Oncology pharmacists and cancer patients are talking about.

Interested in contributing to a future episode? Got a topic suggestion? We'd love to hear from you.
Email us at communications@hoparx.org

Podcast Insights

Content Themes

The podcast primarily focuses on topics relevant to Hem/Onc pharmacy professionals and cancer patients, with episodes addressing issues such as improving diverse representation in cancer clinical trials and enhancing safety and accessibility in clinical trials. Specific episodes feature discussions on AI applications in healthcare and institutional patient care efforts.

Further Podcast insights, such as show format, guest types, ideal guests, and target audience are available to Podcast Collab Club Members!

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.

 

For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.